Siemens’ MAMMOMAT Improves X-Ray Technology, Reduces Dose

March 4, 2008 - Siemens Healthcare displayed at NCBC its MAMMOMAT Novation S, created to help detect, diagnose and treat breast cancer earlier, faster and with greater precision, designed as a cost-effective solution for facilities that are making the transition to digital breast imaging but do not have the need for the advanced functionality of state-of-the-art systems, at NCBC 2008.

The MAMMOMAT Novation S reportedly optimizes workflow, utilizes the latest full-field amorphous Selenium (aSe) detectors and features Tungsten/Rhodium (W/Rh) X-ray technology, which reduces dose. This approach enables shorter exams, streamlined workflow and improved patient outcomes. With the movement toward a multimodality approach to breast care, imaging technologies such as ultrasound and magnetic resonance imaging (MRI) are playing an increasing role in all stages of breast care..

For more information: www.usa.siemens.com/healthcare